Talking to Employers and Medical Staff About Breast Cancer Treatment and Your Job (NCT03572374)
Breast Cancer and the Workforce: Talking to Employers and Medical Staff About Work (TEAMWork)
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this study is learn more about how being treated for breast cancer affects patients' employment. Researchers are testing an early version of a mobile app designed to help breast cancer patients keep their jobs during and after treatment. The app provides advice for patients to use when having conversations about breast cancer with their employers and their doctors. The app is called TEAMWork (Talking to Employers And Medical staff about Work). In this study, the investigators are asking breast cancer patients who are about to receive treatment or who are currently receiving treatment to tell us what aspects of the app work well, so that they can learn how to improve it.
Who can join: Review the eligibility criteria below.
Location: Memorial Sloan Kettering Basking Ridge (Consent and Follow-up) — Basking Ridge, New Jersey
Age range: 18 Years to 64 Years
🧪 Interventions in This Study
- TEAMWork App (OTHER)
- Information Booklet (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (9 Sites)
- Memorial Sloan Kettering Basking Ridge (Consent and Follow-up) — Basking Ridge, New Jersey
- Memorial Sloan Kettering Monmouth (Consent and Follow-up) — Middletown, New Jersey
- Memorial Sloan Kettering Bergen (Consent and Follow up) — Montvale, New Jersey
- Memorial Sloan Kettering Westchester (Consent and Follow-up) — Harrison, New York
- Queens Cancer Center of Queens Hospital — Jamaica, New York
- Bellevue Hospital Center (Data Collection Only) — New York, New York
- Memorial Sloan Kettering Cancer Center — New York, New York
- Lincoln Medical and Mental Health Center — The Bronx, New York
- Montefiore Medical Center — The Bronx, New York
📞 Contact the Study Coordinator
Phone: (646) 888-4808
Email: blinderv@mskcc.org
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Breast Cancer
- S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer — Anniston, Alabama
- [177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer — Los Angeles, California
- Evaluation And Risk Assessment For Persistent Postsurgical Pain After Breast Surgery — Durham, North Carolina
- TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study B) — Palo Alto, California
- A Multi Modality Surveillance Program for Women At High Risk for Breast Cancer — Chicago, Illinois
- ATOP TRIAL: T-DM1 in HER2 Positive Breast Cancer — Duarte, California
Explore by condition: All Breast Cancer clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.